Twenty-four months clinical outcomes of sirolimus-eluting stents for the treatment of small coronary arteries: The long-term SES-SMART clinical study

European Heart Journal

Volumn 30, Issue 17, 2009, Pages 2095-2101

  Menozzi, Alberto ^a   Solinas, Emilia ^a   Ortolani, Paolo ^b   Repetto, Alessandra ^c   Saia, Francesco ^b   Piovaccari, Giancarlo ^d   Manari, Antonio ^e   Magagnini, Enrico ^f   Vignali, Luigi ^a   Bonizzoni, Erminio ^g   Merlini, Piera Angelica ^h   Cavallini, Claudio ⁱ   Ardissino, Diego ^a  

^a UNIVERSITY HOSPITAL OF PARMA   (Italy)

^b UNIVERSITY OF BOLOGNA   (Italy)

^c FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

^d OSPEDALE DEGLI INFERMI   (Italy)

^e S MARIA NUOVA HOSPITAL   (Italy)

^f UNIVERSITY OF PISA   (Italy)

^g UNIVERSITY OF MILAN   (Italy)

^h OSPEDALE NIGUARDA CA GRANDA   (Italy)

ⁱ SANTA MARIA DELLA MISERICORDIA HOSPITAL   (Italy)

Author keywords

Myocardial infarction; Revascularization; Sirolimus; Small coronary arteries; Stents

Indexed keywords

RAPAMYCIN;

ADULT; ARTICLE; BARE METAL STENT; CARDIOVASCULAR DISEASE; CEREBROVASCULAR ACCIDENT; CLINICAL STUDY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY; DEATH; DRUG ELUTING STENT; FEMALE; FOLLOW UP; HEART INFARCTION; HUMAN; ISCHEMIA; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RESTENOSIS; REVASCULARIZATION; SINGLE BLIND PROCEDURE; TREATMENT OUTCOME;

AGED; CEREBROVASCULAR DISORDERS; CORONARY RESTENOSIS; DEATH, SUDDEN, CARDIAC; DRUG-ELUTING STENTS; FEMALE; HUMANS; KAPLAN-MEIERS ESTIMATE; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; MYOCARDIAL REVASCULARIZATION; PROSPECTIVE STUDIES; RISK FACTORS; SINGLE-BLIND METHOD; SIROLIMUS; TREATMENT OUTCOME; TUBULIN MODULATORS;

EID: 69949153926     PISSN: 0195668X     EISSN: 15229645     Source Type: Journal    
DOI: 10.1093/eurheartj/ehp224     Document Type: Article

References (21)

1. Morice MC, Serruys PW, Sousa JE, Fajadet J, Ban Hayashi E, Perin M, Colombo A, Schuler G, Barragan P, Guagliumi G, Molnàr F, Falotico R, RAVEL Study Group. Randomized Study with the Sirolimus-Coated Bx Velocity Balloon-Expandable Stent in the Treatment of Patients with de Movo Native Coronary Artery Lesions. A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. M Engl J Med 2002:346:1773-1780.
2. Moses JW. Leon MB. Popma JJ. Fitzgerald PJ, Holmes DR, O'shaughnessy C, Caputo RP. Kereiakes DJ, Williams DO, Teirstein PS. Jaeger JL, Kuntz RE. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N EngJ Med 2003;349:1315-1323.
3. 3. Pfisterer M, Brunner-La Rocca HP, Buser PT. Rickenbacher P. Hunziker P, Mueller C, Jeger R, Bader F, Osswald S, Kaiser C, BASKET-LATE Investigators. Late clinical events after clopidogrel discontinuation may limit the benefit of drug-eluting stents: an observational study of drug-eluting versus bare-metal stents. J Am Coll Cardiol 2006;48:2584-2591. (Pubitemid 44881238)
4. 4. Nordmann AJ, Briel M. Bucher HC. Mortality in randomized controlled trials comparing drug-eluting vs. bare metal stents in coronary artery disease: a meta-analysis. Eur Heart J 2006;27:2784-2814. (Pubitemid 44871464)
5. 5. Camenzind E, Steg PG, Wijns W. Stent thrombosis late after implantation of first-generation drug-eluting stents: a cause for concern. Circulation 2007:115: 1440-1455. (Pubitemid 46648381)
6. 6. Fajadet J, Morice MC, Bode C, Barragan P, Serruys PW, Wijns W, Constantini CR, Guermonprez JL. Eltchaninoff H, Blanchard D, Bartorelli A. Laarman GJ, Perin M, Sousa JE. Schuler G, Molnar F, Guagliumi G. Colombo A, Ban Hayashi E. Wülfen E. Maintenance of long-term clinical benefit with sirolimus-eluting coronary stents: three-year results of the RAVEL trial. Circulation 2005:111:1040-1044. (Pubitemid 40354523)
7. Weisz G, Leon MB, Holmes DR, Kereiakes DJ, Clark MR, Cohen BM, Ellis SG, Coleman P, Hill C, Shi C, Cutlip DE. Kuntz RE, Moses JW. Two-year outcomes after sirolimus-eluting stent implantation: results from the Sirolimus-Eluting Stent in de Novo Native Coronary Lesions (SIRIUS) trial. J Am Coll Cardiol 2006; 47:1350-1355.
8. 8. Finn AV, Kolodgie FD, Harnek J, Guerrero LJ, Acampado E, Tefera K, Skorija K, Weber DK, Gold HK, Virmani R. Differential response of delayed healing and persistent inflammation at sites of overlapping sirolimus- or paclitaxel-eluting stents. Circulation 2005:112:270-278. (Pubitemid 40982311)
9. 9. Joner M, Finn AV, Farb A, Mont EK. Kolodgie FD, Ladich E. Kutys R, Skorija K, Gold HK, Virmani R. Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk J Am Coll Cardiol 2006;48:193-202. (Pubitemid 43929240)
10. 10. McFadden EP, Stabile E, Regar E. Cheneau E. Ong AT, Kinnaird T. Suddath WO, Weissman NJ, Torguson R. Kent KM, Pichard AD, Satler LF, Waksman R, Serruys PW. Late thrombosis in drug-eluting coronary stents after discontinuation of antiplatelet therapy. Loncet 2004;364:1519-1521. (Pubitemid 39410418)
11. 11. Artang R. Dieter RS. Analysis of 36 reported cases of late thrombosis in drug-eluting stents placed in coronary arteries. Am J Cardiol 2007:99:1039-1043. (Pubitemid 46560471)
12. 12. Lagerqvist B, James SK, Stenestrand U, Lindback J, Nilsson T, Wallentin L, SCAAR Study Group. Long-term outcomes with drug-eluting stents versus bare-metal stents in Sweden. N Engl J Med 2007;356:1009-1019. (Pubitemid 46376801)
13. 13. Ardissino D. Cavallini C, Bramucci E. Indolfi C, Marzocchi A, Manari A, Angeloni G, Carasio G, Bonizzoni E, Colusso S, Repetto M, Merlini PA. Sirolimus-eluting versus uncoated stents for prevention of restenosis in small coronary arteries: a randomized trial. J Am Med Assoc 2004;292:2727-2734. (Pubitemid 39628251)
14. 14. Kastrati A, Mehilli J, Pache J, Kaiser C, Valgimigli M, Kelbaek H, Menichelli M, Sabaté M. Suttorp MJ, Baumgart D, Seyfarth M, Pfisterer ME. Schömig A. Analysis of 14 trials comparing sirolimus-eluting stents with bare-metal stents. N Engl J Med 2007:356:1030-1039. (Pubitemid 46376803)
15. 15. Spaulding C. Daemen J, Boersma E, Cutlip DE, Serruys PW. A pooled analysis of data comparing sirolimus-eluting stents with bare-metal stents. M EnglJ Med 2007; 356:989-997. (Pubitemid 46376799)
16. 16. Marzocchi A, Saia F, Piovaccari G, Manari A, Aurier E, Benassi A, Cremonesi A, Percoco G, Varani E, Magnavacchi P, Guastaroba P, Grilli R, Maresta A. Long-term safety and efficacy of drug-eluting stents: two-year results of the REAL (REgistro AngiopLastiche dell'Emilia Romagna) multicenter registry. Circulation 2007;115: 3181-3188. (Pubitemid 47012232)
17. 17. Tu JV, Bowen J, Chiu M, Ko DT, Austin PC, He Y, Hopkins R, Tarride JE, Blackhouse G, Lazzam C, Cohen EA, Goeree R. Effectiveness and safety of drug-eluting stents in Ontario. N Engl J Med 2007:357:1393-1402. (Pubitemid 47541971)
18. Brunner-La Rocca HP. Kaiser C. Pfisterer M, on behalf of the BASKET Investigators. Targeted stent use in clinical practice based on evidence from the BAsel Stent Cost Effectiveness Trial (BASKET). Eur Heart J 2007:28:719-725.
19. 19. Settler C, Wandel S, Alleman S, Kastrati A, Morice MC. Schömig A, Pfisterer M, Stone GW. Leon MB. Suarez de Lezo J, Goy JJ. Park SJ, Sabate M, Suttorp MJ. Kelbael H, Spaulding C. Menichelli M, Vermeersch P. Dirksen MT, Cervinka P, Petronio AS, Nordmann AJ, Diem P, Meier B, Zwahlen M, Reichenbach, Trelle S, Windecker S, Jüni P. Outcomes associated with drug-eluting and baremetal stents: a collaborative network meta-analysis. Lancet 2007;370:937-948. (Pubitemid 47393576)
20. 20. Togni M, Eber S, Widmer J, Billinger M, Wenaweser P. Cook S, Vogel R. Seiler C, Eberli FR, Maier W. Corti R, Roffi M, Lüscher TF, Garachemani A, Hess OM, Wandel S, Meier B, Juni P, Windecker S. Impact of vessel size on outcome after implantation of sirolimus-eluting and paclitaxel-eluting stents: a subgroup analysis of the SIRTAX trial. J Am Coll Cardiol 2007:50:1123-1131. (Pubitemid 47375014)
21. Pfisterer M, Brunner-La Rocca HP, Rickenbacher P, Hunziker P, Mueller C, Nietlispach F, Leibundgut G, Bader F, Kaiser C, for the BASKET Investigators. Long-term benefit- risk balance of drug-eluting vs. bare-metal stents in daily practice: does stent diameter matter? Three-year follow-up of BASKET. Eur Heart J 2009;30:16-24.